Advertisers will soon get deeper visibility into how each Display creative performs, enabling smarter optimization decisions.

Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce gold results from the September follow-up exploration program on the new discovery of ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Flight-tracking data show two U.S. B-1 Lancer bombers flew to within six nautical miles of Venezuela on Thursday, records that contradict President Donald Trump denial that U.S. bombers had been sent ...

When Hunt Regional Healthcare closed its freestanding emergency departments in Commerce and Quinlan, the most common explanation circulating in Hunt County was that “too many people were using the ER ...

On the surface, it seems obvious that training an LLM with “high quality” data will lead to better performance than feeding it any old “low quality” junk you can find. Now, a group of researchers is ...

The longest-running independent art fair in the city is scheduled to take place at the Los Angeles Convention Center’s West Hall on Jan. 7-11, 2026, under the direction of Kassandra Voyagis. By Chris ...

Philly students have shown improvement in a number of areas over the past three years, including test scores, but some measures are still far from the targets set by the city’s Board of Education ...

Abstract: Containers have emerged as a prevalent mechanism for deploying software applications within cloud data centers, thereby abstracting many operational details from developers and transferring ...

Abstract: Data augmentation (DA) is an effective approach for enhancing model performance with limited data, such as light field (LF) image super-resolution (SR). LF images inherently possess rich ...

Pluvicto TM plus standard of care (ARPI + ADT) significantly reduced risk of progression or death by 28% (HR 0.72) versus SoC alone, with positive trend in OS (HR 0.84) in PSMA+ metastatic ...

Shares of Grail have quintupled this year to nearly $90, as investors waited for news about the Pathfinder 2 study of its cancer-detecting blood test. Management hinted this summer the numbers were ...